Venous thrombo-embolism as a complication of cross-sex hormone treatment of male-to-female transsexual subjects: a review

Asscheman, H; T'sjoen, G; Lemaire, A; Mas, M; Meriggiola, M C; Mueller, A; Kuhn, Annette; Dhejne, C; Morel-Journel, N; Gooren, L J (2013). Venous thrombo-embolism as a complication of cross-sex hormone treatment of male-to-female transsexual subjects: a review. Andrologia, 46(7), pp. 791-795. Wiley-Blackwell 10.1111/and.12150

[img] Text
and12150.pdf - Published Version
Restricted to registered users only
Available under License Publisher holds Copyright.

Download (71kB) | Request a copy

Administration of cross-sex hormones to male-to-female transsexual subjects, usually oestrogens + often anti-androgens, such as cyproterone acetate, carries a risk of venous thromboembolism (VTE). VTE usually occurs in the first year of oestrogen administration. Ethinyl oestradiol, due to its chemical structure, was in 2003 identified as a major factor in the occurrence of VTE. Most clinics do not prescribe ethinyl oestradiol any longer, but people who take hormones without medical supervision use often oral contraceptives containing ethinyl oestradiol, many times in overdose. Cessation of use of ethinyl oestradiol and peri-operative thrombosis prophylaxis for surgery have reduced prevalence rate of VTE. Other oral oestrogens should not be overdosed, and transdermal oestrogen is to be preferred. Thrombosis prophylaxis for surgery is mandatory. It seems advisable to stop hormone use at least 2 weeks before major surgery, to be resumed only after 3 weeks following full mobilisation.

Item Type:

Journal Article (Original Article)

Division/Institute:

04 Faculty of Medicine > Department of Gynaecology, Paediatrics and Endocrinology (DFKE) > Clinic of Gynaecology

UniBE Contributor:

Kuhn, Annette

Subjects:

600 Technology > 610 Medicine & health

ISSN:

1439-0272

Publisher:

Wiley-Blackwell

Language:

English

Submitter:

Nathalie Ursula Becher

Date Deposited:

03 Jun 2015 13:17

Last Modified:

11 Nov 2015 09:25

Publisher DOI:

10.1111/and.12150

PubMed ID:

23944849

Uncontrolled Keywords:

Cross-sex hormones; ethinyl oestradiol; oestrogen; transsexual; venous thrombosis

BORIS DOI:

10.7892/boris.54054

URI:

https://boris.unibe.ch/id/eprint/54054

Actions (login required)

Edit item Edit item
Provide Feedback